Inhibition of p53 prevents diabetic cardiomyopathy by preventing early-stage apoptosis and cell senescence, reduced glycolysis, and impaired angiogenesis
2018 · Cell Death and Disease · 107 citations
https://doi.org/10.1038/s41419-017-0093-5
J
Junlian Gu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
66
Papers
2.4K
Citations
28
h-index
41
i10-index
Junlian Gu is an academic researcher from Shandong University. The author has contributed to research in topics: Fibroblast Growth Factor Research & Genomics, phytochemicals, and oxidative stress & Chemotherapy-induced cardiotoxicity and mitigation. The author has an h-index of 28, co-authored 57 publications.
ORCID: 0000-0001-8146-1260Papers by this author
worksUncoupling the Mitogenic and Metabolic Functions of FGF1 by Tuning FGF1-FGF Receptor Dimer Stability
2017 · Cell Reports · 99 citations
https://doi.org/10.1016/j.celrep.2017.06.063
Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2
2022 · Redox Biology · 93 citations
https://doi.org/10.1016/j.redox.2022.102310
Cholesterol mediated ferroptosis suppression reveals essential roles of Coenzyme Q and squalene
2023 · Communications Biology · 61 citations
https://doi.org/10.1038/s42003-023-05477-8
SESN2-Mediated AKT/GSK-3β/NRF2 Activation to Ameliorate Adriamycin Cardiotoxicity in High-Fat Diet–Induced Obese Mice
2023 · Antioxidants and Redox Signaling · 9 citations
https://doi.org/10.1089/ars.2022.0156
Diabetes-associated sleep fragmentation impairs liver and heart function via SIRT1-dependent epigenetic modulation of NADPH oxidase 4
2025 · Acta Pharmaceutica Sinica B · 3 citations
https://doi.org/10.1016/j.apsb.2024.12.031
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat